sequenc
phylogenet
analysi
found
bat
origin
divers
possibl
intermedi
host
includ
pangolin
mice
rat
mani
similar
origin
sarscov
use
comput
model
xu
et
al
found
spike
protein
sarscov
almost
ident
structur
receptorbind
domain
maintain
van
der
waal
forc
sarscov
spike
protein
strong
bind
affin
human
base
biochem
interact
studi
crystal
structur
analysi
sarscov
spike
protein
share
ident
amino
acid
sequenc
importantli
sarscov
spike
protein
high
degre
homolog
wan
et
al
report
residu
glutamin
receptorbind
domain
rbd
correspond
residu
sarscov
recogn
critic
lysin
human
receptor
analysi
even
suggest
recogn
human
effici
sarscov
increas
abil
transmit
person
person
thu
spike
protein
predict
also
strong
bind
affin
human
similar
sarscov
critic
function
sarscov
receptor
vitro
vivo
requir
host
cell
entri
subsequ
viral
replic
overexpress
human
enhanc
diseas
sever
mous
model
sarscov
infect
demonstr
viral
entri
cell
critic
step
inject
sarscov
spike
mice
worsen
lung
injuri
critic
injuri
attenu
block
reninangiotensin
pathway
depend
express
thu
sarscov
pathogenesi
entri
receptor
viru
also
protect
lung
injuri
therefor
previous
suggest
contrast
coronavirus
sarscov
becam
highli
lethal
viru
deregul
lung
protect
pathway
zhou
et
al
demonstr
overexpress
differ
speci
hela
cell
human
pig
civet
mous
allow
infect
replic
therebi
directli
show
use
cellular
entri
receptor
demonstr
use
coronaviru
receptor
aminopeptidas
n
dipeptidyl
peptidas
summari
spike
protein
directli
bind
host
cell
surfac
receptor
facilit
viru
entri
replic
key
question
lung
appear
vulner
target
organ
one
reason
vast
surfac
area
lung
make
lung
highli
suscept
inhal
virus
also
biolog
factor
use
normal
lung
tissu
eight
adult
donor
zhao
et
al
demonstr
cell
alveolar
epitheli
type
ii
cell
aecii
suggest
cell
serv
reservoir
viral
invas
addit
gene
ontolog
enrich
analysi
show
aecii
high
level
multipl
viral
processrel
gene
includ
regulatori
gene
viral
process
viral
life
cycl
viral
assembl
viral
genom
replic
suggest
aecii
facilit
coronavir
replic
lung
express
receptor
also
found
mani
extrapulmonari
tissu
includ
heart
kidney
endothelium
intestin
importantli
highli
express
lumin
surfac
intestin
epitheli
cell
function
coreceptor
nutrient
uptak
particular
amino
acid
resorpt
food
therefor
predict
intestin
might
also
major
entri
site
infect
might
initi
eat
food
wuhan
market
put
site
outbreak
whether
inde
infect
human
gut
epithelium
import
implic
fecalor
transmiss
contain
viral
spread
tissu
distribut
organ
could
explain
multiorgan
dysfunct
observ
patient
note
howev
accord
center
diseas
control
prevent
whether
person
get
touch
surfac
object
viru
touch
mucu
membran
yet
confirm
sever
potenti
therapeut
approach
fig
develop
subunit
proteinbas
vaccin
may
reli
fact
receptor
cell
line
facilit
viral
replic
presenc
may
effici
largescal
vaccin
product
inhibit
transmembran
proteas
serin
activ
hoffman
et
al
recent
demonstr
initi
spike
protein
prime
transmembran
proteas
serin
essenti
entri
viral
spread
interact
receptor
serin
proteas
inhibitor
camostat
mesyl
approv
japan
treat
unrel
diseas
shown
block
activ
thu
interest
candid
interact
site
sarscov
identifi
atom
level
studi
date
also
hold
true
interact
thu
one
could
target
interact
site
antibodi
small
molecul
kuba
et
al
demonstr
mice
sarscov
downregul
protein
ace
bind
spike
protein
contribut
sever
lung
injuri
suggest
excess
may
competit
bind
neutral
viru
also
rescu
cellular
activ
neg
regul
reninangiotensin
system
ra
protect
lung
injuri
inde
enhanc
ace
activ
decreas
avail
contribut
lung
injuri
acidand
ventilatorinduc
lung
injuri
thu
treatment
solubl
form
may
exert
dual
function
slow
viral
entri
cell
henc
viral
spread
protect
lung
injuri
notabl
recombin
human
found
safe
neg
hemodynam
effect
healthi
volunt
small
cohort
patient
ard
administr
rapidli
decreas
level
proteolyt
target
peptid
angiotensin
ii
trend
lower
plasma
concentr
previou
work
sarscov
pathogenesi
make
ration
scientif
valid
therapeut
target
current
pandem
avail
recombin
impetu
assembl
multin
team
intensivist
scientist
biotech
rapidli
initi
pilot
trial
patient
sever
clinicaltrialsgov
josef
penning
founder
sharehold
apeiron
compani
make
arthur
slutski
paid
consult
apeiron
conflict
interest
report
articl
licens
creativ
common
attributionnoncommerci
intern
licens
permit
noncommerci
use
share
adapt
distribut
reproduct
medium
format
long
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licenc
indic
chang
made
imag
third
parti
materi
articl
includ
articl
creativ
common
licenc
unless
indic
otherwis
credit
line
materi
materi
includ
articl
creativ
common
licenc
intend
use
permit
statutori
regul
exce
permit
use
need
obtain
permiss
directli
copyright
holderto
view
copi
licenc
visit
http
creat
iveco
mmon
orglicen
potenti
approach
address
follow
infect
find
sarscov
use
receptor
cell
entri
import
implic
understand
transmiss
pathogenesi
sarscov
like
lead
downregul
receptor
ace
bind
spike
protein
lead
viral
entri
replic
well
sever
lung
injuri
potenti
therapeut
approach
includ
spike
proteinbas
vaccin
transmembran
proteas
serin
inhibitor
block
prime
spike
protein
block
surfac
receptor
use
antibodi
peptid
solubl
form
slow
viral
entri
cell
competit
bind
henc
decreas
viral
spread
well
protect
lung
injuri
uniqu
enzymat
function
masrmitochondri
assembl
receptor
ii
type
receptor
